Davis W J, Pang L M, Chernack W J, Mellins R B
Chest. 1977 Nov;72(5):614-7. doi: 10.1378/chest.72.5.614.
Forty-eight children with known asthma (ranging in age from 2 to 16 years) were studied during an acute attack. Each received either terbutaline or epinephrine subcutaneously in a random double-blind fashion. Measurement of heart rate, respiratory rate, and systemic arterial systolic and diastolic blood pressures and careful clinical assessment of obstruction of the airway were made before and at 15, 30, and 60 minutes after the administration of the drugs. Appreciable and significant clinical improvement was noted in 19 of the 24 patients in both groups and was of comparable magnitude. A small, but significant, increase in heart rate was noted in those patients requiring only one injection of terbutaline, suggesting that the drug's selectivity for the lung is relative not absolute. The present study demonstrates that terbutaline is an effective bronchodilator drug in acute childhood asthma.
48名已知患有哮喘的儿童(年龄在2至16岁之间)在急性发作期间接受了研究。每个儿童以随机双盲方式皮下注射特布他林或肾上腺素。在给药前以及给药后15、30和60分钟测量心率、呼吸频率、全身动脉收缩压和舒张压,并对气道阻塞情况进行仔细的临床评估。两组24名患者中有19名出现了明显且显著的临床改善,且改善程度相当。仅需注射一次特布他林的患者心率出现了小幅但显著的增加,这表明该药物对肺部的选择性是相对的而非绝对的。本研究表明,特布他林是治疗儿童急性哮喘的一种有效支气管扩张剂药物。